{"id":25866,"date":"2011-10-04T06:27:07","date_gmt":"2011-10-04T06:27:07","guid":{"rendered":"https:\/\/drprem.com\/guide\/international-body-denies-clinical-trial-on-hiv-aids\/"},"modified":"2011-10-04T06:27:07","modified_gmt":"2011-10-04T06:27:07","slug":"international-body-denies-clinical-trial-on-hiv-aids","status":"publish","type":"post","link":"https:\/\/drprem.com\/globalhealthcare\/international-body-denies-clinical-trial-on-hiv-aids","title":{"rendered":"International body denies clinical trial on HIV \/AIDS"},"content":{"rendered":"
\n<\/a>\n<\/div>\n

<![CDATA[<\/p>\n

An Indian HIV vaccine that gave encouraging results in the first phase of clinical trial is being given a silent burial with the International AIDS Vaccine Initiative now claiming (IAVI) that the vaccine would not be fully stable in commercial production. However, sources close to the vaccine development alleged that the vaccine was 97 per cent stable way back in 2002 and the rest could have been worked out had the IAVI paid more attention to the indigenous vaccine. IAVI has refuted the charge point blank.<\/p>

\n<\/a>\n<\/div>\n\n

The vaccine based on the common Indian strain of HIV was developed through a collaboration between Indian Council of Medical Research and National Institutes of Health USA. The vaccine was then manufactured by US company Therion Biologicals.<\/p>\n

After successful animal studies in mice and rabbits, the vaccine was put through two rounds of phase-I clinical trails between 2006 and 2009. In the first trial, it was tried alone and second time in a prime-boost mode with another DNA vaccine.<\/p>\n<\/p>\n

Ref and Read more: https:\/\/www.deccanherald.com\/content\/190526\/hopes-indigenous-hiv-vaccine-fade.html<\/a><\/p>\n

]]> \t<\/p>\n

\n

\r\n <\/a><\/p>\r\n